Panel Discussion: In-Use Stability: Current Practices, Emerging Requirements, Expectations, Challenges and Trends
DATE: 09 May 2024
TIME:
12:00 pm to 12:50 pm PST
2:00 pm to 2:50 pm CST
3:00 pm to 3:50 pm EST
Please join us for an engaging panel discussion titled: In-Use Stability: Current Practices, Emerging Requirements, Expectations, Challenges and Trends.
The discussion will be driven by questions from community members and the audience on each of the following topics on in-use stability and panelists will share their experience and views:
- Inputs into In-Use Study Design
- Methods and Specifications
- Study Timing and Sample Selection
- Sample Handling and Exposure
We hope you will be able to join us in the discussion on 9th May, as we participate in knowledge sharing and professional development.
This session was organized by the AAPS Stability Community Leadership Team: Sherilyn Campie, Kim HuynhBa, Vinaya Kapoor, Lori McCaig, Dan Willingmyre and Kayla Woodlief.
Panelists
Vinaya Kapoor, PhD, Sr Director, Head of Regulatory Affairs CMC, Arcus Biosciences
Danielle Leiske, PhD, Director, Pharmaceutical Development, AbCellera
Jing Liu, PhD, Director, Business Strategy and Operation, Pfizer
Tony Mazzeo, PhD, Associate Scientific Director, Product Development-ASO, Stability, BMS
Nanda Subbarao, PhD, Sr Consultant, Biologics Consulting Group
Sarah Weiser, MS, Sr Principal Scientist, Pfizer
Moderators
Sherilyn Campie, MS, Director, QC Stability, Coherus Bio Sciences
Kim HuynhBa, MS, Managing Director, Pharmalytik
Dan Willingmyre, Associate Director, Stability and Data Analytics, Vir Biotechnology Inc.
MEETING INFORMATION
No registration is necessary.
The discussion will begin promptly at 12:00 pm PST/2:00 pm CST/3:00 pm EST.
Link for Joining Virtual Panel Discussion
Join Zoom Meeting
https://temple.zoom.us/j/91403480752
Meeting ID: 914 0348 0752
One tap mobile
+13092053325,,91403480752# US
+13126266799,,91403480752# US (Chicago)
Kind Regards,
Dan Willingmyre
Associate Director, Stability & Data Analytics
Email: [email protected] | Phone: +1 415 449 8993
Vir Biotechnology, Inc. | www.vir.bio
